Related references
Note: Only part of the references are listed.TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin
Daniel Chappell et al.
BASIC RESEARCH IN CARDIOLOGY (2009)
Heparinase selectively sheds heparan sulphate from the endothelial glycocalyx
Daniel Chappell et al.
BIOLOGICAL CHEMISTRY (2008)
INCREASED LEVELS OF GLYCOSAMINOGLYCANS DURING SEPTIC SHOCK: RELATION TO MORTALITY AND THE ANTIBACTERIAL ACTIONS OF PLASMA
Axel Nelson et al.
SHOCK (2008)
Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis
Arash Afshari et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia
Markus Rehm et al.
CIRCULATION (2007)
Antithrombin reduces pulmonary hypertension during reperfusion after cardiopulmonary bypass in a pig
M. Jormalainen et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2007)
The endothelial glycocalyx affords compatibility of Starting's principle and high cardiac interstitial albumin levels
Matthias Jacob et al.
CARDIOVASCULAR RESEARCH (2007)
Endothelial glycocalyx: Sweet shield of blood vessels
Jurgen W. VanTeeffelen et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2007)
Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability
Matthias Jacob et al.
ANESTHESIOLOGY (2006)
Clinical review: Molecular mechanisms underlying the role of antithrombin in sepsis
Christian J. Wiedermann
CRITICAL CARE (2006)
Role of platelets and serine proteinases in coupling of blood coagulation and inflammation
SM Strukova
BIOCHEMISTRY-MOSCOW (2004)
Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed
M Rehm et al.
ANESTHESIOLOGY (2004)
被撤回的出版物: Antithrombin reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation through promotion of prostacyclin production (Retracted article. See vol. 122, pg. 302, 2013)
A Mizutani et al.
BLOOD (2003)
Tissue factor and thrombin mediate myocardial ischemia-reperfusion injury
AJ Chong et al.
ANNALS OF THORACIC SURGERY (2003)
Antithrombin: a new look at the actions of a serine protease inhibitor
J Roemisch et al.
BLOOD COAGULATION & FIBRINOLYSIS (2002)
Influence of antithrombin on ischemia/reperfusion injury in the isolated blood-free perfused rat heart
J Margreiter et al.
THROMBOSIS RESEARCH (2002)
Quality of life effects of antithrombin III in sepsis survivors: results from the KyberSept trial [ISRCTN22931023]
D Rublee et al.
CRITICAL CARE (2002)
Antithrombin III prevents early pulmonary dysfunction after lung transplantation in the dog
A Salvatierra et al.
CIRCULATION (2001)
Treatment of porcine sepsis with high-dose antithrombin III reduces tissue edema and effusion but does not increase risk for bleeding
G Dickneite et al.
BLOOD COAGULATION & FIBRINOLYSIS (2001)
Induction of inflammatory mediators during reperfusion of the human heart
G Valen et al.
ANNALS OF THORACIC SURGERY (2001)
Influence of the endothelial glycocalyx on cerebral blood flow in mice
J Vogel et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2000)
Therapeutic rationale for antithrombin III in sepsis
SM Opal
CRITICAL CARE MEDICINE (2000)